Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 03/30/23 → 02/12/25 |
Funding
- Kowa Research Institute Incorporated: $21,863.37
A Phase 3, Prospective, Double-masked, Randomized, Multi-center, Vehicle-controlled, Parallel-group, 12-week Administration and 40-week Extension Study Confirming the Efficacy and Safety of K-161 Ophthalmic Solution for the Treatment of Mod
- Honkanen, Robert A. (PI)
- Chou, Timothy (CoPI)
- Weissbart, Sarah (CoPI)
Project: Research